We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hysterectomy Surgery Safer Than Endometrial Ablation

By HospiMedica International staff writers
Posted on 25 Sep 2019
Laparoscopic supracervical hysterectomy (LASH) for women with heavy menstrual bleeding is as safe as endometrial ablation, but much more effective, claims a new study.

Researchers at the University of Aberdeen (United Kingdom), the University of Glasgow (United Kingdom), Aberdeen Royal Infirmary (United Kingdom), and other institutions conducted a randomized controlled trial in 31 hospitals in Scotland that included 660 women younger than 50 years who were referred to a gynecologist for surgical treatment of heavy menstrual bleeding (menorrhagia), and who were eligible for endometrial ablation.

The patients were randomly allocated to either LASH or second-generation endometrial ablation. More...
The results revealed that 97% of the women allocated to LASH were satisfied with their operation, compared to 87% in the endometrial ablation group. In addition, 69% of the women randomly assigned to LASH were also more likely to have the best possible menorrhagia multi-attribute quality of life scale (MMAS) score (100) than women assigned to endometrial ablation (54%). The study was published on September 12, 2019, in The Lancet.

“This study shows that LASH offers a more effective option than endometrial ablation, without any increased risks,” said lead author consultant gynecologist Professor Kevin Cooper, MD, of the University of Aberdeen. “Most women having this procedure get home within 24 hours and there are no restrictive rules for recovery, unlike traditional hysterectomy. Laparoscopic supracervical hysterectomy offers women another effective surgical choice for this common medical condition.”

Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Menorrhagia generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. In addition, women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.

Related Links:
University of Aberdeen
University of Glasgow
Aberdeen Royal Infirmary

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.